May 19, 2026 04:14AM
Nov 24, 2025 05:53AM
Jun 3, 2025 08:19AM
Apr 8, 2025 10:19AM
Mar 7, 2025 05:03AM
Jul 2, 2024 02:24PM
Nov 27, 2023 11:21AM Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS
Nov 27, 2023 04:08AM
Jun 13, 2022 04:57PM
Mar 16, 2022 06:47AM
May 4, 2021 04:15PM
May 9, 2018 04:05PM
Jan 9, 2018 08:07AM
Sep 25, 2017 10:15AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $172 at UBS; 'Lowering Erwinase & Defitelio Sales Estimates' on Symphony Sales Data
May 16, 2017 04:05PM
Jan 18, 2017 06:22AM
Aug 25, 2016 10:36AM
May 18, 2016 04:05PM
May 11, 2016 09:05AM
Apr 13, 2016 09:33AM
Mar 31, 2016 07:21AM Jazz (JAZZ) U.S. Defitelio Approval Expected but Adds Another Growth Driver, UBS Says; PT to $162
Feb 24, 2016 09:20AM
Oct 19, 2015 10:01AM
Jun 29, 2015 08:40AM
May 15, 2015 04:05PM
Nov 5, 2014 09:11AM
Jan 21, 2014 01:15PM
Aug 7, 2013 12:50PM Jazz Pharmaceuticals (JAZZ) Fundamentals Remain Strong, PT Raised - UBS
Feb 27, 2013 12:52PM
Nov 29, 2012 07:42AM
Aug 1, 2011 03:08PM
Nov 5, 2010 11:05AM
Sep 20, 2010 02:43PM
May 17, 2010 10:45AM
Dec 9, 2009 11:07AM Notable Analyst Rating Changes for 12/9: S, MMM, CA, RNWK, NYX Upgraded; KR, ACN, LLL, LMT, RTN, MDAS Downgraded
Aug 11, 2009 05:38PM
Jun 26, 2009 09:44AM
Jun 11, 2009 09:50AM

169,932 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All